Oxidative stress modulation in alcohol-related liver disease: From chinese botanical drugs to exercise-based interventions
Authors:
Open Access
- 25 April 2025
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 16, 1516603
Abstract
Alcohol-related liver disease (ALD) is a chronic liver injury caused by long-term excessive alcohol consumption, with complex and multifaceted pathological mechanisms. Research indicates that oxidative stress (OS), inflammatory responses, and lipid metabolic disturbances induced by alcohol and its metabolites are primary contributors to hepatocyte injury, positioning OS as a key target in ALD treatment. The main non-pharmacological treatment for ALD is alcohol abstinence, while medical treatment primarily relies on Western pharmacological interventions. However, recent research has increasingly highlighted the potential of Chinese botanical drugs in improving histological features and modulating signaling pathways associated with OS in ALD, underscoring the therapeutic potential of traditional Chinese herb medicine. Despite these promising findings, the precise mechanisms and effects of these extracts remain incompletely understood, and potential side effects must be considered. Therefore, a comprehensive analysis of herbal extracts with therapeutic effects is essential to optimize clinical administration and ensure safe, effective treatment. This review focuses on OS as a central theme, categorizing Chinese botanical drugs into six major groups—flavonoids, polyphenols, terpenoids, alkaloids, saponins, and anthraquinones—all widely used in traditional Chinese herb medicine. The review provides an overview of their botanical characteristics and therapeutic actions in the context of ALD, offering insights into OS regulation and exploring their potential as treatments for ALD. Notably, physical exercise shares overlapping mechanisms with botanical drugs in regulating OS. Combining two strategies could offer a promising integrative treatment for ALD, though further research is needed to confirm their synergistic benefits and optimize clinical applications.Keywords
This publication has 134 references indexed in Scilit:
- Contributing roles of mitochondrial dysfunction and hepatocyte apoptosis in liver diseases through oxidative stress, post-translational modifications, inflammation, and intestinal barrier dysfunctionCellular and Molecular Life Sciences, 2024
- Insights of mitochondrial involvement in alcoholic fatty liver diseaseJournal of Cellular Physiology, 2023
- Curcumin: A dietary phytochemical for boosting exercise performance and recoveryFood Science & Nutrition, 2022
- Endoplasmic reticulum stress in liver diseasesHepatology, 2022
- Dioscin: A review on pharmacological properties and therapeutic valuesBioFactors, 2021
- Targeting Nrf-2 is a promising intervention approach for the prevention of ethanol-induced liver diseaseCellular and Molecular Life Sciences, 2018
- Curcumin attenuates ethanol‐induced hepatic steatosis through modulating Nrf2/FXR signaling in hepatocytesIUBMB Life, 2015
- Puerarin: A Review of Pharmacological EffectsPhytotherapy Research, 2013
- Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating Kupffer cell polarization in miceHepatology, 2011
- Oxidative stress, metabolism of ethanol and alcohol-related diseasesJournal of Biomedical Science, 2001